Editorial

This issue of OR Manager is being published just about a year after the nationwide shutdown that was implemented to curb the spread of SARS-CoV-2, the virus that causes COVID-19. Failures on many fronts ensued in the months that followed, with an excessive death toll and unprecedented disruptions in every aspect of life throughout 2020. At the same time, amazing progress was made in the development of new vaccines, two of which the US Food and Drug Administration approved under Emergency Use Authorization (EUA) by year end. EUA of a third vaccine followed in February 2021.